IT has been shown that the affected muscles of patients suffering from myasthenia gravis contain more potassium than normal muscles (Cumings, 1939b) , and that after the subcutaneous administration vf prostigmin to myasthenic patients, the concentration of potassium in their muscles fell to a normal level, and also in one of the cases recorded in that paper the serum potassium was observed to rise as the muscle potassium fell. The present paper deals with a study of the fate of the potassium leaving the muscles.
Neither patient received prostigmin or any other therapy for the first two experimental days, but on the third each was given prostigmin (mgm. 1) subcutaneously at the end of one of the 4-hourly periods (at 4 p.m.). Each day from the fourth day to the end of the experimental period both patients were given 3 gms. of potassium in the form of dipotassium hydrogen phosphate. The measure was washed out with distilled water after each dose and the washings administered to the patients. Further subcutaneous injections of prostigmin (mgm. 1) were given at 4 p.m. on the sixth day to one patient, and on the seventh day to the other patient, blood being taken before and 45 minutes after the injections. The experimental periods ended 40 hours after these last injections of prostigmin.
The potassium in the blood sera, urines, faces, and foods was determined by the method previously used (Cumings,-1939a) . The inorganic phosphate in the urine and faces were estimated by Fiske and Subbarow's method (1925) .
Results
Effect of Prostigmin on the Serum Potassium.- Table 1 shows the amounts of potassium found in the serum before and after the injection of prostigmin in the two patients and also in three normal subjects after one dose of prostigmin. The figures show that no alteration in serum potassiunl took place in the normal persons, but in both patients the administration of prostigmin was followed by an increase in the serum potassium, and that adding very large amounts of potassium to the diet raised the resting level of the serum potassium, but did not prevent the increase of that level after prostigmin. Clinically the effect of the prostigmin injection was excellent. The general muscular improvement was particularly rapid in the case of Miss M., who experienced considerable difficulty in swallowing.
Intake of Potassium.-Before considering the excretion of potassium, the daily intake of that substance is shown in Table 2 . It is seen that apart from the first day there was a fairly constant amount of potassium in the food. It would seem unlikely therefore that the small variation in the potassium intake could account for the alterations in the level of serum potassium which followed the injection of prostigmin. group.bmj.com on April 13, 2017 -Published by http://jnnp.bmj.com/ Downloaded from urinary excretion of potassium consequent on the rise of serum potassium after prostigmin should have been seen within this same period.
The excretion of potassium in the stools is shown in Table 3 . It is seen that no increased excretion of potassium has taken place at any time except on the fifth day of the experimental period in the case of Miss M. This is probably due to the slightly larger quantity of stool and because the patient was somewhat constipated for the first few days. Excretion ofInorganic Phosphate.-The figures for the excretion of inorganic phosphate in the urine and faces from the two patients are given at the end of the paper, and it can be seen that no significant alterations have taken place as the result of the prostigmin injections. Table 4 shows the potassium balances of the two patients over the whole period of the experiment. Table 1 ). It seemed possible that some of this amount might have been found in the urine within a few hours after the administration of prostigmin. The urinary excretion of potassium, however, did not increase after prostigmin, Although the potassium in the diet varied somewhat from day to day, this variation did not cause any fluctuation of potassium excretion such that the sudden excretion of 0 5 gm. of potassium would not have been easily apparent. (Figs. 1 and 2, It would seem that the potassium liberated from the muscles into the blood must have remained for a time in the blood and then to have returned to the muscles. This seems the more probable since the potassium in the muscles rises again when the action of prostigmin wears off (vide infra). A patient, Mr. J., with severe myasthenia gravis was receiving four and sometimes five doses of prostigmin daily, and although each dose produced a rapid clinical improvement this improvement persisted for only about 4 hours. A biopsy was performed 2 hours after a dose of prostigmin ; 33 hours after this injection the patient became very weak and another sample of muscle was removed, after which prostigmin (mgm. 1) was again given. A third sample of muscle was taken i hour later. Blood was taken each time muscle was removed. The potassium found in the three specimens of sera and in the three samples of muscle were estimated, and the results are seen in Table 5 together with the values for the phosphate found in the muscles. It is seen that the levels of potassium found in the second and third samples of muscle are in agreement with those recorded in my previous paper, and, moreover, that there was a slight increase in the amount of potassium found in the muscle 2 hours after prostigmin, as compared with the amount found after j hour. It is also seen that the amount of potassium in the muscle increased considerably between 2 and 3i hours after prostigmin, during which time the clinical condition of the patient deteriorated. It therefore appears that the degree of muscular weakness is associated with the amount of potassium present in the muscle.
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